3rd World Congress on Cancer Science & Therapy
Upcoming SlideShare
Loading in...5

3rd World Congress on Cancer Science & Therapy






Total Views
Views on SlideShare
Embed Views



2 Embeds 4

http://www.mdconferencefinder.com 3
https://twitter.com 1


Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
Post Comment
Edit your comment

3rd World Congress on Cancer Science & Therapy 3rd World Congress on Cancer Science & Therapy Document Transcript

  • Cancer Science-2013 October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, USA 3rd World Congress on Cancer Science & Therapy Conference Secretariat 5716 Corsa Ave., Suite 110, West Lake, Los Angeles, CA 91362-7354, USA Ph: +1-650-268-9744, Fax: +1-650-618-1414, Toll free: +1-800-216-6499 Email: cancerscience-2013@omicsonline.net cancerscience2013@omicsgroup.us
  • OMICS Group welcomes you to attend the 3rd World Congress on Cancer Science & Therapy during October 21-23, 2013 at DoubleTree by Hilton Hotel San Francisco Airport, USA. We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of Cancer Science & Therapy. Cancer Science-2013 anticipates more than 500 participants around the globe with thought provoking Keynote lectures, Oral presentations and Poster presentations. The attending delegates include Editorial Board Members of OMICS Group Journals & Eminent Professionals across the globe. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists. The intending participants can confirm their participation by registering for the conference along with your colleagues, avail the delegate early bird offer. The main theme of the conference is “Innovations and Novel Therapeutic strategies in Cancer Science” Dorothee Herlyn, The Wistar Institute, Philadelphia, USA Porunelloor A. Mathew, University of North Texas Health Science Center, USA King-Thom Chung, The University of Memphis, USA Deryl Troyer, Johnson Cancer Research Center, USA David Yu, Emory University School of Medicine, USA Junran Zhang, Case Western Reserve University, USA Gregory Lee, University of British Columbia, USA Alexandru Almasan, Cleveland Clinic Foundation, USA Alex Bishop, University of Texas Health Science Center, USA Karen M. Vasquez, The University of Texas at Austin, USA Guang Peng, MD Anderson Cancer Center, USA Warren C Ladiges, University of Washington, USA Chuying Du, University of Cincinnati College of Medicine, USA Anisha R. Kumar, Stanford University School of Medicine, USA Ettore Murabito, University of Manchester, USA Karli Rosner, Barbara Ann Karmanos Cancer Institute, USA Panikar Wadhera, Brooklyn hospital center, USA Kinfe Redda, Florida A&M University, USA Kaiyi Li, Baylor College of Medicine, USA Afshin Amini, The University of New South Wales, Australia Anahid Ehteda, The University of New South Wales, Australia Bill E. Cham, Australasian Institute of Medical Research, Australia Judy Wilyman, University of Wollongong, Australia Samar Masoumi Moghaddam, The University of New South Wales, Australia Sarah Harten, Queensland Institute of Medical Research, Australia Jens Thiele, St. Georg Hospital, Germany Jens Buentzel, Suedharz Klinikum Nordhausen, Germany Christine Bolz, Vienna, Austria Martin Bolz, Vienna, Austria Fruhmann Johanna, Medical University Hospital Graz, Austria Shiaw-Yih Lin, The University of Texas MD Anderson Cancer Center, USA Akbar Khan, Medicor Cancer Centres, Canada Geng Bian, Anhui Provincial Hospital, China Guodong Shen, Anhui Provincial Hospital, China Jianhong Zhu, Medical School of Nanjing University, China Min Hu Anhui, Provincial Hospital, China Shiyang Pan, Nanjing Medical University, China Suoqin Tang, Chinese PLA General Hospital, China Wei Li, Nanjing Medical University of Hangzhou Hospital, China Andre Luis, Branco de Barros Federal University of Minas Gerais, Brazil Monica Oliveira, Federal University of Minas Gerais, Brazil Elisangela de Paula Silveira Lacerda, Universidade Federal de Goias, Brazil Elcio Moreira Alves, University Center of Patos de Minas, Brazil Thais Helena Gasparoto, University of Sao Paulo, Brazil Alvaro Macieira-Coelho, French National Institute of Health, France Dominique Ledoux, University of Paris, France Mohand-Akli BOUKHIAR, University of Paris, France Aurelio Flores Garcia, Mexico Michela Zanardi, ASLTO2 SAN GIOVANNI BOSCO HOSPITAL, Italy Maha Salama, Cairo University, Egypt Shahira Ezzat, Cairo University, Egypt Sona Pekova, Chambon Laboratory, Czech Republic Daniel Diaz, Charles University Ruben Karapetian, Chemical Diversity Research Institute, Russia Dona Sinha, Chittaranjan National Cancer Institute, India Rita Isaac, Christian Medical College, Vellore Alvaro Macieira-Coelho, French National Institute of Health, France Masanori Nakanishi, General Nanto Hospital, Japan Roland B Sennerstam, Karolinska Hospital, Sweden IBRAHIM ALSWAIDAN, King Saud University Aly H. Nada, Kuwait University, Kuwait Prateek Jain, Manipal University, India Mohamed El-Far, Mansoura University, Egypt Wen-Chun Hung, National Health Research Institutes, Taiwan Oluf Dimitri Røe, Norwegian University of Science and Technology (NTNU), Norway Kiran Dahiya, Pt. B. D. Sharma PGIMS MoisesArmides Molina, Universidad Autonoma de Nuevo Leon, Mexico Angel Josabad Alonso-Castro, Universidad Autonoma Metropolitana campus, Mexico Vagner R. Santos, Universidade Federal de Minas Gerais Stefania Staibano, University of Neples Federico II, Italy Manuela Stoicescu, University of Oradea, Romania Dominique Ledoux, University of Paris, France Mohand-Akli BOUKHIAR, University of Paris, France Jason Moffat, University of Toronto, Canada John Rothman, Update Pharma Inc. Jozef Oleksyszyn, Wroclaw University of Technology, Poland 200 more speakers from World wide... Welcome Message Cancer Science-2013 Part of confirmed attendees from renowned Universities, Research institutes Companies and Labs includes...
  • Event Partners Organizing Committee Members Stewart Sell University of Albany USA Abe Eric Sahmoun University of North Dakota USA Jimmy T. Efird Brody School of Medicine USA Shiaw-Yih Lin The University of Texas USA Reza Hakkak University of Arkansas USA Jeffrey A Ross Health Effects Research Laboratory, USA Yoshiaki Omura New York Medical College USA Samir A Farghaly Cornell University USA Tetsuya Konishi Niigata University of Pharmacy & Applied Life Sciences, Japan Zhimin (James) Lu University of Texas USA Anupam Bishayee American University of Health Sciences, USA Liang Xu University of Kansas USA Nearly 80% of Cancer Science-2013 attendees are involved in their lab’s purchasing decisions Sponsor or Exhibit @ Cancer Science-2013 Cancer Science-2013 is probably the most relevant meeting for many companies. If you are supplying products of basic medical/Cancer research, this is a captive audience and it appears to be the who’s who in the field of Cancer Science Available booth will be assigned on a first-come, first-served basis Scientific Sessions • Cancer Therapy and Clinical Cancer Research • Cancer Cell Biology, Diagnostic and Prognostic Cancer Biomarkers • Organ-Specific Cancers, Cancer Genetics, Drug Development and Diagnostics • Carcinogenesis and Mutagenesis and OMICS in Cancer Research • Advances in Cancer Detection, Imaging, Management and Prevention • Anti-Cancer Drug Discovery and Development • Innovation Technologies in Cancer Research • Tumor Science • Novel Approaches to Cancer Therapeutics • Metabolomics of cancer Note: Abstracts can be submitted on any of the following topics for presentations to individual interest, but not limited to the above sessions. The intend behind this is to broaden the scope of the meetings by covering new developments. Additionally, abstracts with a primary focus on medicine are greatly encouraged and will be designated in the program as applied sessions. Register now for the conference by choosing an appropriate package suitable to you.
  • About OMICS Group Special Issues All accepted abstracts will be published in respective OMICS Group Journals Each abstract will be provided with digital Object Identifier by OMICS Group Journals • 300 Open Access Journals • 21 Days rapid review process • 20000 Editorial team • 25000 Reviewers team • 2 Million readers • Publication within 7 days of acceptance • Quality and quick editorial, review processing Key features • User friendly/feasible website translation of your paper to 50 world’s leading languages • Enhanced feature: Audio version of published paper • Digital articles to share and explore • Sharing Option: Social networking enabled • Authors, reviewers and editors are provided with scientific credits “Workshop on laboratory animal models for Cancer Therapy” • Key eminent includes !! Dorothee Herlyn The Wistar Institute, USA Ze’ev Ronai Sanford-Burnham Medical Research Institute at La Jolla George Xu University of Pennsylvania, USA Clemens Krepler The Wistar Institute, USA Martin McMahon UCSF, USA Highlights of Cancer Science-2013 • Plenary session • EB Meeting • Speaker sessions • Workshop • Young Research Forum • Poster sessions • Best poster awards • Quality review process • Exhibitions and much more... OMICS Group Conferences • 80 Conferences all over the World in 2013 • Well organized scientific program • Well known delegates and speakers across the globe Key features • Presentation by renowned speakers from all over the world • Poster presentations and world class exhibits • Interactive Sessions • Platform for global networking • Connecting scientific community Cancer Science-2013
  • The field of Cancer Science is growing rapidly and its development is making tremendous impact in medical sciences and pharmaceuticals. The importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. Cancer Science-2013 • Opportunity to attend the presentations delivered by eminent scientists from all over the world • Selected contributions will be published in following OMICS Group Journals, • Journal of Cancer Science & Therapy • Journal of Carcinogenesis & Mutagenesis • Journal of Chemotherapy • Participation in sessions on specific topics on which the conference is expected to achieve progress • Global networking: In transferring and exchanging ideas Cancer Science-2013 Registration Details Register Online http://www.omicsgroup.com/conferences/cancer-science-therapy-2013/registration.php Register Offline http://www.omicsgroup.com/conferences/ACS/conference/pdfs/cancerscience2013_eform_usa.pdf Important Dates EARLY Bird closes on August 27 2013 Abstract submission closes on October 6 2013 On spot registration: October 21, 2013
  • San Francisco, officially the City and County of San Francisco, is the fourth most populous city in California and the 12th most populous city in the United States, with a 2008 estimated population of 808,977. The only consolidated city- county in California, it encompasses a land area of 46.7 square miles (121 km2 ) on the northern end of the San Francisco Peninsula. Today, San Francisco is a popular international tourist destination, renowned for its chilly summer fog, steep rolling hills, eclectic mix of Victorian and modern architecture and its famous landmarks, including the Golden Gate Bridge, cable cars, and Chinatown. The city is also a principal banking and finance center, and the home to more than 30 international financial institutions, helping to make San Francisco eighteenth place in the world’s top producing cities, ninth in the United States, and fifteenth place in the top twenty Global Financial Centers. San Francisco is unique in that a few of its parks and nearly all of its beaches within city limits form part of the regional Golden Gate National Recreation Area, which is one of the most visited units of the National Park system in the United States, with over 13 million visitors a year. It is also one of the largest urban parks in the world. The beaches and parks that form the Golden Gate National Recreation Area in San Francisco include Ocean Beach runs along the Pacific Ocean shoreline and is frequented by a vibrant surfing community; Baker Beach which is located in a cove west of the Golden Gate and part of the former military base, the Presidio. Within the Presidio is Crissy Field, a former airfield that was restored to its natural salt marsh ecosystem. The GGNRA also administers Fort Funston, Lands End, Fort Mason, and Alcatraz. The National Park Service also separately administers the San Francisco Maritime National Historical Park-a fleet of historic ships and waterfront property around Aquatic Park. About San Francisco Cancer Science-2013
  • Cancer Science-2013 Venue DoubleTree by Hilton Hotel San Francisco Airport 835 Airport Blvd., Burlingame, California, 94010-9949, USA Tel: +1-650-344-5500 Transport Facilities San Francisco International Airport General Arrival Directions: From the North (San Francisco and San Francisco Airport) - Take Highway 101 South to Broadway/Burlingame exit (East). Go east over overpass; remain in the right lane. Turn right at the first light (Old Bayshore Rd) and left at the next light onto Airport Blvd. Follow the road around until you see hotel on your right side, approximately a quarter of a mile. DIRECTIONS from ‘San Francisco International Airport’ Distance from Hotel: 2 mi. Drive Time: 10 min. Get Turn-by-Turn Directions: • Depart from San Francisco Int’l Airport, CA (0.3 mi.) • Take ramp right for US-101 South toward San Jose (2.6 mi.) • At exit 419B, take ramp right for Broadway toward Bayshore Hwy / Airport Blvd (0.2 mi.) • Turn right onto Rollins Rd (0.1 mi.) • Turn right onto Broadway (0.3 mi.) • Turn right onto Bayshore Hwy / Old Bayshore Hwy (0.1 mi.) • Turn left onto Airport Blvd (0.7 mi.) • Arrive at Airport Blvd on the right (0.0 mi.) DIRECTIONS from ‘Metropolitan Oakland International’ Distance from Hotel: 28 mi. Drive Time: 50 min. Get Turn-by-Turn Directions: • Depart Airport Dr toward 2 (0.4 mi.) • Keep left to stay on Airport Dr (1.1 mi.) • Turn right onto CA-61 / Doolittle Dr (0.9 mi.) • Bear left onto CA-61 / CA-112 / Davis St (0.3 mi.) • Bear right onto CA-61 E / CA-112 E / Davis St (0.1 mi.) • Take ramp right for I-880 South toward San Jose (6.7 mi.) • At exit 27, take ramp right for CA-92 West toward San Mateo Br (13.1 mi.) • At exit 13B, take ramp right for US-101 toward San Jose / San Francisco (4.1 mi.) • At exit 419A, take ramp right and follow signs for Anza Blvd (0.2 mi.) • Keep straight onto Anza Blvd (0.2 mi.) • Turn right onto Airport Blvd (0.0 mi.) • Arrive at Airport Blvd on the right (0.0 mi.) DIRECTIONS from ‘San Jose International Airport’ Distance from Hotel: 30 mi. Drive Time: 45 min. Get Turn-by-Turn Directions: • Depart Airport Blvd toward Airport Pkwy (0.9 mi.) • Bear left onto road (0.4 mi.) • Take ramp left for CA-87 N / Guadalupe Pkwy (0.7 mi.) • At exit 9B, take ramp left for US-101 North toward San Francisco (28.6 mi.) • At exit 419A, take ramp right and follow signs for Anza Blvd (0.2 mi.) • Keep straight onto Anza Blvd (0.2 mi.) • Turn right onto Airport Blvd (0.0 mi.) • Arrive at Airport Blvd on the right (0.0 mi.) Type Typical Minimum Charge Courtesy Bus 24 hour complimentary Taxi 20.00 USD